financetom
Business
financetom
/
Business
/
China's latest trade truce with US leaves investors none the wiser
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's latest trade truce with US leaves investors none the wiser
Jun 11, 2025 12:12 AM

NEW YORK/SINGAPORE (Reuters) -The latest trade truce between China and the United States offered investors the hope of an eventual deal that the feuding superpowers can live with, though the possibility of another tariff flare-up remained a risk for markets.

The muted market reaction told its own story, as U.S. and Chinese officials ended two days of talks in London on Tuesday with pledges to revive an agreement struck last month in Geneva, and remove China's export restrictions on rare earths - a sticking point in that deal.

The guarded welcome from currency and stock investors shows that while the meeting ended in a truce, markets had also hoped for more and the lack of details means uncertainty is likely to remain high.

The main positive takeaway was the talks indicated pragmatism on both sides, analysts said.

"This is positive news to the market. At least now there's a bottom line that neither side is willing to cross," said Mark Dong, co-founder of Minority Asset Management in Hong Kong.

Chinese stocks rose to near three-week highs, while U.S. stock futures were a touch lower. The U.S. dollar edged higher and China's yuan was steady.

"For now, as long as the headlines of talks between the two parties remain constructive, risk assets should remain supported," said Chris Weston, head of research at Australian broker Pepperstone.

"The devil will be in the details but the lack of reaction suggests this outcome was fully expected."

Markets plunged after U.S. President Donald Trump's "Liberation Day" tariff announcement on April 2 as investors worried about an impending recession but those fears eased as Trump rolled back most of the punitive tariffs, lifting stocks.

The benchmark S&P 500 index has risen 6.5% since then and is close to reclaiming a record high. Chinese stocks have underperformed as investors fret over a persistently weak economy but have nonetheless recouped losses to be back at the April 2 level.

TARIFF REPRIEVE

The latest plan to re-ink a deal might remove some of the extreme gloom scenarios for markets, but investors would need more concrete steps to fully rejoice.

The broad impact of the sweeping duties in a trade war that could bring $600 billion in two-way trade to a standstill is being felt in both economies. Economists expect the damage from the tit-for-tat duties and volatility in financial markets would be an overhang on the global economy for months.

Phillip Wool, chief research officer and lead portfolio manager at Rayliant Global Advisors, said investors bidding stocks back to record highs were significantly underestimating the damage already caused by such uncertainty this year.

"I'm feeling more cautious and opportunistic than unconditionally bullish at this moment," he said. "If any major deal is reached, we could see stocks rally in response, but my sense is that's more emotion at this point, and the euphoria could be short-lived as new risks materialize."

China's economy needs the reprieve from tariffs that have hit its exports as the country battles deep deflationary pressures and weak consumption.

Moreover, while the ultimate impact on U.S. inflation and the jobs market from the trade war remains to be seen, tariffs have hammered U.S. business and household confidence.

That has left the dollar under pressure, down over 8% against major rivals this year, as investors worry about the U.S. economy and fiscal health. Trump's big bill to cut taxes and spend more has exacerbated worries about U.S. debt.

Right now, the challenges facing Trump are aplenty, including a spectacular fallout with the world's richest person, Elon Musk, a tax bill that is under intense scrutiny and street protests in Los Angeles over his administration's immigration policy.

That raises the stakes for a successful negotiation with China, and investors aren't ready to make hard bets on the outcome just yet.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dollar recovers from PMI slump, yen closes in on 155 per dollar
Dollar recovers from PMI slump, yen closes in on 155 per dollar
Apr 24, 2024
LONDON (Reuters) -The U.S. dollar regained some ground on Wednesday following big falls against the euro and sterling the day before, while the yen remained mired near 34-year lows even as Japanese officials stepped up intervention warnings. The dollar index - which measures the currency against six major peers including the euro, sterling and yen - was last up 0.2%...
SK Hynix to invest $3.86 billion in DRAM chip production base in South Korea
SK Hynix to invest $3.86 billion in DRAM chip production base in South Korea
Apr 24, 2024
SEOUL (Reuters) - South Korean memory chipmaker SK Hynix said on Wednesday it plans to invest 5.3 trillion won ($3.86 billion) to build a chip factory for a new dynamic random access memory (DRAM) chip production base in South Korea. The Nvidia supplier plans to start construction at the chip factory, called M15X, at the end of April with an...
Travere Therapeutics Says Berger's Disease Treatment Granted EU Conditional Marketing Authorization
Travere Therapeutics Says Berger's Disease Treatment Granted EU Conditional Marketing Authorization
Apr 24, 2024
04:27 AM EDT, 04/24/2024 (MT Newswires) -- Travere Therapeutics ( TVTX ) and CSL Vifor said Wednesday the European Commission granted conditional marketing authorization for Filspari as a treatment for adults with primary Immunoglobulin A Nephropathy, or Berger's disease. CSL Vifor expects to launch sales of the drug in Europe beginning in H2. The authorization for the treatment, also known...
FOXO Technologies Gets Non-Compliance Notice From NYSE American
FOXO Technologies Gets Non-Compliance Notice From NYSE American
Apr 24, 2024
04:01 AM EDT, 04/24/2024 (MT Newswires) -- FOXO Technologies ( FOXO ) said late Tuesday it received a notice from the NYSE American that it is not compliant with the exchange's listing rules due to its failure to timely file its 2023 annual report on Form 10-K. The delay was attributed to significant changes and restructuring activities in 2023 and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved